BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 17147082)

  • 21. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multifactorial prognostic analysis in the surgical treatment of well differentiated thyroid neoplasms].
    Zani B; Tirone G; Valduga P; Silvestri M; Eccher C
    Minerva Chir; 2002 Aug; 57(4):475-9. PubMed ID: 12145578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular thyroid carcinoma: prognostic factors and the role of radioiodine.
    Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Yuen KT; Law CC; Lau WH
    Cancer; 2002 Aug; 95(3):488-98. PubMed ID: 12209740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
    Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
    Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surgical treatment of differentiated carcinoma of the thyroid. Follow-up of 99 cases].
    Pozzetto B; Roseano M; Dellach C; Leggeri A
    Chir Ital; 2000; 52(1):49-56. PubMed ID: 10832526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymph node dissection in papillary or follicular thyroid carcinoma.
    Bononi M; Tocchi A; Cangemi V; Vecchione A; Giovagnoli MR; De Cesare A; Fiori E; Volpino P; Brozzetti S; Meucci M; Scozzafava S; Cavallaro A
    Anticancer Res; 2004; 24(4):2439-42. PubMed ID: 15330196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
    Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
    J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
    Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
    Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differentiated cancer of the thyroid: prognostic aspects].
    Veroux P; Fazzi C; Cavallaro A; Veroux M; Cannizzaro MA
    Chir Ital; 1997; 49(1-2):37-41. PubMed ID: 12743874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large remnant 131I ablation as an alternative to completion/total thyroidectomy in the treatment of well-differentiated thyroid cancer.
    Leblanc G; Tabah R; Liberman M; Sampalis J; Younan R; How J
    Surgery; 2004 Dec; 136(6):1275-80. PubMed ID: 15657587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of lymph node metastases in well-differentiated and medullary thyroid cancer: retrospective study on 52 cases].
    Antonelli AR; Piazza C; Lombardi D; Casigli F
    Ann Ital Chir; 2004; 75(3):305-14. PubMed ID: 15605518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome after treatment of papillary thyroid microcarcinoma.
    Appetecchia M; Scarcello G; Pucci E; Procaccini A
    J Exp Clin Cancer Res; 2002 Jun; 21(2):159-64. PubMed ID: 12148571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgical treatment of differentiated thyroid carcinoma].
    Guercioni G; Siquini W; Taccaliti A; Marmorale C
    Ann Ital Chir; 2003; 74(5):501-9. PubMed ID: 15139704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical treatment of well-differentiated thyroid carcinoma invading trachea: a report of 15 cases].
    Wu GH; Li H; Chen FJ; Zeng ZY; Chen WK; Peng HW; Zhang Q; Yang AK; Song M; Tan GM; Wei MW; Yu WB
    Ai Zheng; 2004 Nov; 23(11 Suppl):1498-501. PubMed ID: 15566666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of lymph node metastases in follicular thyroid cancer.
    Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
    World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of tumour size in papillary and follicular thyroid cancer.
    Passler C; Scheuba C; Asari R; Kaczirek K; Kaserer K; Niederle B
    Br J Surg; 2005 Feb; 92(2):184-9. PubMed ID: 15685703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.